about
Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antiretroviral Pharmacokinetics in Pregnant Women.
@en
type
label
Antiretroviral Pharmacokinetics in Pregnant Women.
@en
prefLabel
Antiretroviral Pharmacokinetics in Pregnant Women.
@en
P2093
P2860
P356
P1433
P1476
Antiretroviral Pharmacokinetics in Pregnant Women.
@en
P2093
Elise M Gilbert
Kristin M Darin
Milena M McLaughlin
P2860
P304
P356
10.1002/PHAR.1626
P407
P50
P577
2015-08-21T00:00:00Z